Intragastric Balloon Market to Witness Significant Growth Due to Increasing Health Consciousness Among Consumers

Intragastric Balloon Market Introduction

Intragastric balloon (IGB) is a non-surgical weight loss procedure in which a balloon is inserted into the stomach to reduce its volume, leading to a feeling of fullness and satiety. The IGB market has been growing in recent years due to increasing prevalence of obesity, rising demand for minimally invasive weight loss procedures, and technological advancements in IGBs.

Market research on the intragastric balloon market can help businesses understand the market dynamics, identify growth opportunities, and make informed decisions about product development, marketing, and expansion. The research can cover various aspects of the market, including:

Industry analysis: Analysis of the overall market size, growth trends, and key players in the intragastric balloon market.
Market trends: Identification of current and future market trends, such as technological advancements, increasing demand for minimally invasive procedures, and rising prevalence of obesity.
Market size and forecast: Estimation of the market size and growth forecast for the intragastric balloon market, including revenue, volume, and market share.
Competitive landscape: Analysis of the competitive landscape, including market share analysis, product offerings, and business strategies of key players.
Segmentation: Segmentation of the intragastric balloon market based on product type, end-user, and geography.
Drivers and challenges: Analysis of the key drivers and challenges affecting the growth of the intragastric balloon market, such as regulatory issues, high cost, and potential complications.
Opportunities: Identification of growth opportunities for businesses operating in the intragastric balloon market, such as untapped markets and emerging technologies.
Consumer behavior: Analysis of consumer behavior and preferences, such as patient satisfaction and willingness to pay for IGBs.

Overall, research on the intragastric balloon market can provide valuable insights for businesses to make informed decisions about their products and strategies, and to capitalize on the growth opportunities in this rapidly evolving market.

Intragastric Balloon Market Industry Analysis

The intragastric balloon market is a growing industry that is expected to continue expanding in the coming years. Intragastric balloons are non-surgical weight loss devices that are placed inside the stomach to help patients lose weight. The devices work by creating a feeling of fullness, which reduces appetite and helps patients eat less.

Market Size and Growth

According to a report by Market Research Future, the global intragastric balloon market is expected to grow at a compound annual growth rate of 15.9% from 2017 to 2023. The market was valued at USD 203.5 million in 2016 and is expected to reach USD 378.7 million by 2023.

The growth of the market is driven by several factors, including the increasing prevalence of obesity and the rising demand for non-surgical weight loss procedures. In addition, the growing awareness about the benefits of intragastric balloons and the increasing adoption of minimally invasive procedures are also contributing to the growth of the market.

Geographical Segmentation

The global intragastric balloon market is segmented into four regions: North America, Europe, Asia-Pacific, and the Rest of the World.

North America is the largest market for intragastric balloons, accounting for a significant share of the global market. The growth of the market in this region is driven by the high prevalence of obesity and the increasing demand for non-surgical weight loss procedures.

Europe is the second-largest market for intragastric balloons, with significant growth expected in the coming years. The market in this region is driven by the increasing awareness about the benefits of intragastric balloons and the rising demand for minimally invasive procedures.

Key Players

Some of the key players operating in the intragastric balloon market include Apollo Endosurgery Inc., Allurion Technologies Inc., Helioscopie Medical Implants, Obalon Therapeutics Inc., ReShape Lifesciences Inc., Silimed, Spatz FGIA Inc., and Districlass Medical SA. These companies are investing in research and development activities to improve the effectiveness of intragastric balloons and expand their market presence.

Conclusion

The intragastric balloon market is a growing industry that is expected to continue expanding in the coming years. The increasing prevalence of obesity and the rising demand for non-surgical weight loss procedures are driving the growth of the market. North America is currently the largest market for intragastric balloons, while Asia-Pacific is expected to be the fastest-growing market in the coming years. Key players in the market are investing in research and development activities to improve the effectiveness of intragastric balloons and expand their market presence.

Intragastric Balloon Market Trends

The intragastric balloon market is experiencing several trends that are shaping the industry. These include:

Increasing demand for non-surgical weight loss procedures: As more people become aware of the risks associated with obesity, there is a growing demand for safe and effective weight loss procedures that do not require surgery. Intragastric balloons are seen as a viable alternative to bariatric surgery for patients who are not eligible for or do not want to undergo surgery.
Advancements in technology: The intragastric balloon market is constantly evolving, with new technologies being developed to improve the effectiveness and safety of the devices. For instance, some companies are developing balloons that can be filled with gas instead of liquid, which reduces the risk of leakage and eliminates the need for removal after six months.
Increasing adoption of minimally invasive procedures: Intragastric balloons are considered minimally invasive procedures, which means they require less downtime and have fewer side effects compared to surgery. This is driving their adoption among patients who want to lose weight but are hesitant to undergo surgery.
Growing awareness about the benefits of intragastric balloons: As more studies are conducted on the effectiveness and safety of intragastric balloons, there is a growing awareness about their benefits among healthcare providers and patients. This is driving the demand for the devices, particularly in regions where obesity is a major health concern.
Emerging markets: The intragastric balloon market is expected to experience significant growth in emerging markets such as Asia-Pacific, where the prevalence of obesity is increasing rapidly. This presents an opportunity for companies to expand their market presence and tap into new revenue streams.

Intragastric Balloon Market Size And Forecast

The global intragastric balloon market size was valued at USD 203.5 million in 2016 and is expected to reach USD 378.7 million by 2023, growing at a compound annual growth rate (CAGR) of 15.9% during the forecast period from 2017 to 2023. The market is primarily driven by the increasing prevalence of obesity, the rising demand for non-surgical weight loss procedures, and the growing awareness about the benefits of intragastric balloons.

North America is currently the largest market for intragastric balloons, accounting for a significant share of the global market. The growth of the market in this region is driven by the high prevalence of obesity and the increasing demand for non-surgical weight loss procedures. Europe is the second-largest market, with significant growth expected in the coming years. The market in this region is driven by the increasing awareness about the benefits of intragastric balloons and the rising demand for minimally invasive procedures.

Asia-Pacific is expected to be the fastest-growing market for intragastric balloons, driven by the increasing prevalence of obesity and the rising demand for weight loss procedures in countries such as India and China. The Rest of the World is also expected to experience significant growth during the forecast period, owing to the increasing adoption of intragastric balloons in countries such as Brazil and South Africa.

Intragastric Balloon Market Share Analysis

The intragastric balloon market is highly competitive, with several players operating in the market. Some of the key players in the market include Apollo Endosurgery, Allurion Technologies, ReShape Lifesciences, Obalon Therapeutics, Silimed, Districlass Medical, Lexel, Spatz FGIA Inc., Helioscopie Medical Implants, and Tulip Medical.

Apollo Endosurgery is one of the leading players in the market, with a significant market share. The company offers a range of intragastric balloons, including Orbera and ReShape, which are designed to help patients lose weight in a non-surgical manner. Allurion Technologies is another key player in the market, with its Elipse intragastric balloon system gaining popularity in recent years. The Elipse system does not require endoscopy or anesthesia for insertion or removal, making it a more convenient option for patients.

Other players in the market include ReShape Lifesciences, which offers the ReShape Duo intragastric balloon system, and Obalon Therapeutics, which offers the Obalon balloon system. These companies have a significant presence in the market and are expected to continue to compete for market share in the coming years.

Geographically, North America is the largest market for intragastric balloons, followed by Europe and Asia-Pacific. However, Asia-Pacific is expected to be the fastest-growing market in the coming years, driven by the increasing prevalence of obesity and the rising demand for non-surgical weight loss procedures.

Overall, the intragastric balloon market is expected to remain competitive in the coming years, with players competing for market share through product innovation, marketing strategies, and expansion into new geographic markets.

Intragastric Balloon Market Competitive Landscape

These companies compete with each other on the basis of product quality, pricing, brand recognition, and distribution network. In order to maintain their position in the market, these companies are adopting various strategies such as mergers and acquisitions, partnerships and collaborations, and product launches.

For instance, Apollo Endosurgery acquired the Orbera intragastric balloon system from Johnson & Johnson in 2018, which helped the company expand its product portfolio and strengthen its position in the market. Similarly, Allurion Technologies has entered into partnerships with several distributors to expand its geographic presence and reach more customers.

In addition to these strategies, companies are also investing in research and development to develop new and innovative products that offer better weight loss outcomes and fewer side effects. For instance, Obalon Therapeutics is developing a swallowable intragastric balloon system that does not require endoscopy or anesthesia for insertion or removal.

Intragastric Balloon Market Intelligence

The intragastric balloon market is a rapidly growing segment of the medical device industry, driven by the increasing prevalence of obesity and the rising demand for non-surgical weight loss procedures. The market is highly competitive, with several players operating in the market and competing for market share.

Some of the key players in the market include Apollo Endosurgery, Allurion Technologies, ReShape Lifesciences, Obalon Therapeutics, Silimed, Districlass Medical, Lexel, Spatz FGIA Inc., Helioscopie Medical Implants, and Tulip Medical. These companies compete with each other on the basis of product quality, pricing, brand recognition, and distribution network.

In order to maintain their position in the market, these companies are adopting various strategies such as mergers and acquisitions, partnerships and collaborations, and product launches. They are also investing in research and development to develop new and innovative products that offer better weight loss outcomes and fewer side effects.

Intragastric Balloon Market Industry Trends

The intragastric balloon market is experiencing several trends that are shaping the industry and driving growth. Some of the key trends in the industry include:

Increasing prevalence of obesity: The rising prevalence of obesity worldwide is a major driver of growth in the intragastric balloon market. Obesity is a major health issue that can lead to several other health problems, and the demand for non-surgical weight loss procedures is increasing as a result.
Rising demand for minimally invasive procedures: There is a growing trend towards minimally invasive procedures, driven by the desire to reduce the risk of complications and minimize downtime. Intragastric balloons offer a non-surgical approach to weight loss that can be less invasive than traditional weight loss surgeries.
Technological advancements: The development of new technologies is enabling the production of more advanced intragastric balloon systems. This includes the development of swallowable balloons that do not require endoscopy or anesthesia for insertion or removal.
Increasing awareness about the benefits of intragastric balloons: As more people become aware of the benefits of intragastric balloons, demand for these devices is likely to increase. Intragastric balloons can offer significant weight loss benefits, and can also help to improve overall health by reducing the risk of other health problems associated with obesity.
Growing demand from emerging markets: The intragastric balloon market is expected to experience significant growth in emerging markets, driven by the increasing prevalence of obesity and the rising demand for weight loss procedures. Countries such as India, China, and Brazil are expected to be major growth markets for the industry in the coming years.

Overall, the intragastric balloon market is expected to continue growing in the coming years, driven by these and other industry trends. Companies in the market are likely to continue investing in research and development to develop new and innovative products that offer better weight loss outcomes and fewer side effects, and to expand their geographic presence in order to reach more customers.

Intragastric Balloon Market Analysis

The market can be segmented on the basis of product type, filling material, end-user, and region. By product type, the market can be segmented into single intragastric balloon and dual intragastric balloon. By filling material, the market can be segmented into saline-filled balloons and gas-filled balloons. By end-user, the market can be segmented into hospitals, clinics, and ambulatory surgical centers.

Overall, the intragastric balloon market is expected to continue growing in the coming years, driven by the increasing demand for non-surgical weight loss procedures, the growing awareness about the benefits of intragastric balloons, and the advancements in technology. The market is highly competitive, and companies in the industry will need to continue innovating and investing in order to maintain their position in the market.

Intragastric Balloon Market Segmentation

The intragastric balloon market can be segmented based on various factors, including product type, filling material, end-user, and region. Here are some details about each segmentation:

Product type: Intragastric balloons can be segmented into single intragastric balloon and dual intragastric balloon. Single intragastric balloons are the most commonly used type of intragastric balloon, which are placed in the stomach and inflated with a fluid or gas. Dual intragastric balloons consist of two connected balloons, which can increase the volume of the stomach and promote weight loss.
Filling material: Intragastric balloons can be filled with either saline or gas. Saline-filled balloons are the most common, which are filled with a saline solution. Gas-filled balloons, on the other hand, are filled with gas and can be easier to insert and remove.
End-user: The intragastric balloon market can be segmented into hospitals, clinics, and ambulatory surgical centers. Hospitals are the largest end-users of intragastric balloons, owing to the availability of resources and expertise to perform these procedures.
Region: The intragastric balloon market can be segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America and Europe are currently the largest markets for intragastric balloons, owing to the high prevalence of obesity and increasing demand for non-surgical weight loss procedures. Asia-Pacific is expected to be the fastest-growing market, driven by the increasing prevalence of obesity and the rising demand for weight loss procedures in countries such as India and China.

Segmentation based on these factors helps to provide a better understanding of the market and its dynamics. Companies can use this information to target specific segments and develop strategies to increase their market share.

Intragastric Balloon Market Forecast

The intragastric balloon market is expected to continue growing in the coming years, driven by the increasing prevalence of obesity and the rising demand for non-surgical weight loss procedures. According to a report by Market Research Future, the global intragastric balloon market is expected to grow at a CAGR of 11.2% during the forecast period of 2019-2025.

North America is currently the largest market for intragastric balloons, owing to the high prevalence of obesity and increasing demand for non-surgical weight loss procedures. Europe is the second-largest market, with significant growth expected in the coming years. The Asia-Pacific region is expected to be the fastest-growing market, driven by the increasing prevalence of obesity and the rising demand for weight loss procedures in countries such as India and China.

Single intragastric balloons are the most commonly used type of intragastric balloon, and the segment is expected to continue dominating the market during the forecast period. Saline-filled balloons are the most common type of filling material used in intragastric balloons, and this segment is also expected to continue dominating the market.

Hospitals are the largest end-users of intragastric balloons, owing to the availability of resources and expertise to perform these procedures. However, the market for ambulatory surgical centers is expected to grow at a faster rate during the forecast period, owing to the increasing demand for outpatient procedures and the availability of advanced technologies.

Overall, the intragastric balloon market is expected to continue growing during the forecast period, driven by the increasing demand for non-surgical weight loss procedures and the advancements in technology. The market is highly competitive, and companies will need to continue innovating and investing in order to maintain their position in the market.

Intragastric Balloon Market Growth

The intragastric balloon market is expected to experience significant growth in the coming years. The rising prevalence of obesity, increasing demand for non-surgical weight loss procedures, and advancements in technology are all factors contributing to this growth.

According to a report by Market Research Future, the global intragastric balloon market is expected to grow at a CAGR of 11.2% during the forecast period of 2019-2025. North America and Europe are currently the largest markets for intragastric balloons, while the Asia-Pacific region is expected to experience the fastest growth.

The market is highly competitive, with a large number of players vying for market share. Key players in the intragastric balloon market include Apollo Endosurgery, Allurion Technologies, Helioscopie Medical Implants, ReShape Lifesciences, and Spatz FGIA Inc.

Innovation and investment are critical factors for companies looking to maintain their position in the market. In recent years, there have been advancements in intragastric balloon technology, such as the development of adjustable and swallowable balloons. Additionally, companies are investing in research and development to improve the safety and effectiveness of intragastric balloons, which will further drive market growth.

Overall, the intragastric balloon market is expected to experience significant growth in the coming years, driven by factors such as the increasing prevalence of obesity, rising demand for non-surgical weight loss procedures, and advancements in technology.

Intragastric Balloon Market Competitor Analysis

The intragastric balloon market is highly competitive, with a large number of players vying for market share. Some of the key players in the market include:

Apollo Endosurgery: Apollo Endosurgery is a medical technology company that specializes in developing minimally invasive surgical devices. The company’s ORBERA intragastric balloon is one of the leading products in the market.
Allurion Technologies: Allurion Technologies is a medical device company that specializes in developing non-surgical weight loss devices. The company’s Elipse intragastric balloon is a swallowable balloon that does not require endoscopy or anesthesia.
Helioscopie Medical Implants: Helioscopie Medical Implants is a medical device company that specializes in developing minimally invasive devices for the treatment of obesity. The company’s Spatz3 adjustable intragastric balloon is one of the most advanced products in the market.
ReShape Lifesciences: ReShape Lifesciences is a medical device company that specializes in developing non-surgical weight loss devices. The company’s ReShape Dual Balloon is a saline-filled balloon that is designed to occupy more space in the stomach than traditional intragastric balloons.
Spatz FGIA Inc.: Spatz FGIA Inc. is a medical device company that specializes in developing adjustable intragastric balloons. The company’s Spatz3 adjustable intragastric balloon can be adjusted to optimize weight loss and minimize side effects.

These companies are investing in research and development to improve the safety and effectiveness of intragastric balloons. Additionally, they are focused on developing new products and expanding their presence in emerging markets to maintain their position in the competitive intragastric balloon market.

Intragastric Balloon Market Strengths

The intragastric balloon market has several strengths that contribute to its growth and potential for success, including:

Non-surgical weight loss option: Intragastric balloons offer a non-surgical weight loss option for individuals who are unable or unwilling to undergo traditional weight loss surgery. This makes it a desirable option for a broader range of patients.
Minimal side effects: Compared to weight loss surgery, intragastric balloons have minimal side effects and a shorter recovery time. This makes it an attractive option for patients who want to avoid the risks associated with surgery.
Short procedure time: The placement of an intragastric balloon is a minimally invasive procedure that can be completed in a relatively short amount of time. This makes it a convenient option for both patients and physicians.
Improvements in technology: The intragastric balloon market has seen advancements in technology that have improved the safety and effectiveness of the procedure. For example, adjustable and swallowable balloons have been developed that offer greater customization and convenience for patients.
Increasing prevalence of obesity: The rising prevalence of obesity is driving demand for weight loss solutions, including intragastric balloons. This trend is expected to continue, contributing to the growth of the intragastric balloon market.

Overall, the intragastric balloon market has several strengths that position it for continued growth and success, including its non-surgical nature, minimal side effects, short procedure time, improvements in technology, and increasing demand driven by the rising prevalence of obesity.

Intragastric Balloon Market Opportunities

The intragastric balloon market has several strengths that contribute to its growth and potential for success, including:

Non-surgical weight loss option: Intragastric balloons offer a non-surgical weight loss option for individuals who are unable or unwilling to undergo traditional weight loss surgery. This makes it a desirable option for a broader range of patients.
Minimal side effects: Compared to weight loss surgery, intragastric balloons have minimal side effects and a shorter recovery time. This makes it an attractive option for patients who want to avoid the risks associated with surgery.
Short procedure time: The placement of an intragastric balloon is a minimally invasive procedure that can be completed in a relatively short amount of time. This makes it a convenient option for both patients and physicians.
Improvements in technology: The intragastric balloon market has seen advancements in technology that have improved the safety and effectiveness of the procedure. For example, adjustable and swallowable balloons have been developed that offer greater customization and convenience for patients.
Increasing prevalence of obesity: The rising prevalence of obesity is driving demand for weight loss solutions, including intragastric balloons. This trend is expected to continue, contributing to the growth of the intragastric balloon market.

Intragastric Balloon Market Weakness

The intragastric balloon market presents several opportunities for growth and development, including:

Emerging markets: There are several emerging markets with increasing demand for weight loss solutions, such as China, India, and Brazil. These markets represent significant opportunities for expansion in the intragastric balloon market.
Expansion of indications: While intragastric balloons are primarily used for weight loss, there is potential to expand their indications for other medical conditions, such as type 2 diabetes and nonalcoholic steatohepatitis (NASH).
Increasing awareness: Many individuals may not be aware of the benefits of intragastric balloons as a weight loss solution. Increasing awareness through education and marketing efforts presents an opportunity to reach a wider audience and drive demand.
Improving reimbursement: Reimbursement for intragastric balloons varies by region and may not be covered by insurance in some cases. Improving reimbursement and increasing access to the procedure can help drive growth in the market.
Advancements in technology: Advancements in technology, such as improvements in balloon materials, development of new delivery systems, and integration of sensors, can further improve the safety and effectiveness of intragastric balloons and drive growth in the market.

Overall, the intragastric balloon market presents several opportunities for growth and development, including expansion into emerging markets, expanding indications, increasing awareness, improving reimbursement, and advancements in technology.

Intragastric Balloon Market Threats

The intragastric balloon market may face several threats, including:

Competition: With the increasing popularity of non-invasive weight loss procedures, the intragastric balloon market may face stiff competition from other weight loss procedures, such as gastric sleeve and gastric bypass surgeries.
Side effects: The intragastric balloon procedure has been associated with several side effects, including nausea, vomiting, and abdominal pain. These side effects may deter some potential patients from opting for the procedure.
Reimbursement issues: The cost of intragastric balloon procedures can be high, and insurance companies may not cover the full cost of the procedure. This could limit the market’s growth potential, as patients may not be able to afford the procedure without insurance coverage.
Regulatory hurdles: Regulatory agencies, such as the FDA, have stringent requirements for the approval of medical devices. Delays in obtaining regulatory approval could slow down the growth of the intragastric balloon market.
Limited efficacy: While intragastric balloons have been shown to be effective in helping patients lose weight, some studies suggest that the weight loss may not be sustained in the long term. This could lead to reduced demand for the procedure over time.

It’s important to note that these are potential threats and challenges that the intragastric balloon market may face, and that the market may still continue to grow and evolve over time.

Post Disclaimer

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Market Insight Lab journalist was involved in the writing and production of this article.